Chung Tae Young, Chung Hum, Lee Jin Hak
Department of Ophthalmology, Seoul National University College of Medicine, Seoul, South Korea.
J Cataract Refract Surg. 2002 Nov;28(11):2001-5. doi: 10.1016/s0886-3350(02)01354-8.
To evaluate the effectiveness and safety of combined phacoemulsification, pars plana vitrectomy (PPV), and intraocular lens (IOL) implantation in diabetic and nondiabetic patients and compare the clinical results with those of sequential surgery.
Seoul National University College of Medicine, Seoul, South Korea.
The results of combined phacoemulsification, PPV, and IOL implantation in 52 patients (52 eyes) were retrospectively analyzed. The main outcome measures were preoperative and postoperative best corrected visual acuity (BCVA), postoperative BCVA of 20/40 or better, and intraoperative and postoperative complications. Combined surgery and sequential surgery were also compared using the same outcome measures.
Postoperatively, the BCVA was better in 44 eyes (84.6%); 12 eyes (23.1%) achieved a BCVA of 20/40 or better. Postoperative complications consisted of a transient intraocular pressure increase in 29 eyes (55.8%), hyphema in 10 (19.2%), neovascular glaucoma in 8 (15.4%), anterior chamber fibrin exudation in 7 (13.5%), vitreous hemorrhage in 7 (13.5%), retinal detachment in 3 (5.8%), and posterior capsule opacification in 1 (1.9%). In the diabetic patients, postoperative visual outcomes between the combined-surgery group and the sequential-surgery group were not significantly different; however, neovascular glaucoma occurred only in the combined-surgery group. Other complications were not different between the combined-surgery group and the sequential-surgery group. In the nondiabetic patients, the postoperative visual outcomes and complications between the 2 groups were not significantly different.
Combined phacoemulsification, PPV, and IOL implantation was safe and effective in selected patients, with the clinical outcomes comparable to those of sequential surgery.
评估白内障超声乳化吸除术、玻璃体切除术(PPV)及人工晶状体(IOL)植入联合手术在糖尿病和非糖尿病患者中的有效性和安全性,并将临床结果与序贯手术的结果进行比较。
韩国首尔国立大学医学院。
回顾性分析52例患者(52只眼)接受白内障超声乳化吸除术、PPV及IOL植入联合手术的结果。主要观察指标为术前和术后最佳矫正视力(BCVA)、术后BCVA达到20/40或更好以及术中及术后并发症。还使用相同的观察指标对联合手术和序贯手术进行比较。
术后,44只眼(84.6%)的BCVA有所改善;12只眼(23.1%)的BCVA达到20/40或更好。术后并发症包括29只眼(55.8%)短暂眼压升高、10只眼(19.2%)前房积血、8只眼(15.4%)新生血管性青光眼、7只眼(13.5%)前房纤维蛋白渗出、7只眼(13.5%)玻璃体积血、3只眼(5.8%)视网膜脱离以及1只眼(1.9%)后囊膜混浊。在糖尿病患者中,联合手术组和序贯手术组术后视力结果无显著差异;然而,新生血管性青光眼仅发生在联合手术组。联合手术组和序贯手术组的其他并发症无差异。在非糖尿病患者中,两组术后视力结果和并发症无显著差异。
白内障超声乳化吸除术、PPV及IOL植入联合手术在选定患者中安全有效,临床结果与序贯手术相当。